Regulatory Filings • Aug 4, 2014
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Corporate | 4 August 2014 09:42
Eckert & Ziegler: Cancer irradiation systems installed in Ethiopia for the first time
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Tender Offer/Contract
04.08.2014 / 09:42
Berlin, August 4, 2014. For the first time, a system designed to provide radiation in treating gynecological tumors with brachytherapy sources has been installed in a hospital in Addis Ababa, the capital of Ethiopia, as part of a United Nations aid program for expanding healthcare in Africa. Brachytherapy involves miniaturized, wire-guided radiation sources placed at the site of the tumor, which are especially effective in treating cervical cancer. The GyneSource afterloader was provided by Berlin-based Eckert & Ziegler BEBIG GmbH and was successfully put into operation last month.
Tikur Anbessa (Black Lion) Hospital, one of the largest hospitals in Addis Ababa, was the recipient. It owns the country’s only specialized cancer center and recently began expanding its treatment options with the new afterloader. According to information provided by Ethiopia’s Ministry of Health, there are more than 150,000 cancer cases per year in the country. There have been very few options for treating cancer patients until now.
GyneSource is a multichannel HDR afterloader especially developed for treating gynecological tumors quickly and cost-effectively. It is operated using cobalt radiation sources known for their long service life, which increases cost efficiency. BEBIG is one of the few providers of such equipment, which has helped it to secure success in the healthcare sector of emerging economies. The company works together with United Nations organizations and the World Bank.
About Eckert & Ziegler
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with approximately 700 employees, is one of the world’s largest providers of isotope technology for radiation therapy and nuclear medicine.
Contributing to saving lives
Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com
04.08.2014 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | 49 30 941084-138 |
| Fax: | 49 30 941084-112 |
| E-mail: | [email protected] |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, Düsseldorf, Hamburg, München |
| End of News | DGAP News-Service |
| - - - |
| 280553 04.08.2014 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.